Literature DB >> 25387048

Multimodal imaging of white and dark without pressure fundus lesions.

Amani A Fawzi1, Jared S Nielsen, Aranzazu Mateo-Montoya, Thanapong Somkijrungroj, Helen K Li, John Gonzales, Martine Mauget-Faÿsse, Lee M Jampol.   

Abstract

PURPOSE: To describe multimodal imaging findings in patients with dark or white without pressure lesions of the fundus.
METHODS: Retrospective observational case series of 10 patients with white or dark without pressure lesions. We analyzed multimodal imaging using spectral domain optical coherence tomography, color and near-infrared fundus photography, and fundus autofluorescence imaging to explore the findings associated with these lesions.
RESULTS: All patients had geographic dark or white lesions on clinical examination and color photography, which were either hyporeflective or hyperreflective on near-infrared reflectance imaging, respectively. On optical coherence tomography, these lesions correlated with an abrupt change of the photoreceptor reflectivity, with relative hyporeflectivity of photoreceptor zones (ellipsoid and interdigitation zones, as well as outer segments) within the dark, and relative hyperreflectivity within white lesions. Ten patients underwent fundus autofluorescence, which showed well-defined zones of relative hypo-autofluorescence within the lesion, compared with neighboring uninvolved regions, whether dark or white without pressure. In two patients who had a lesion combining white and dark without pressure, we observed the transition in photoreceptor reflectivity from the dark lesion (hyporeflective) to the white lesion (hyperreflective), relative to the surrounding retina.
CONCLUSION: Both white and dark without pressure lesions are associated with changes in outer retinal reflectivity on optical coherence tomography, which occur in opposite directions compared with the surrounding unaffected areas. In the face of normal visual field testing to date, the clinical significance of this finding remains uncertain. Recognition of the optical coherence tomography appearance will help clinicians avoid unnecessary workup of these patients for outer retinal dystrophy or degeneration.

Entities:  

Mesh:

Year:  2014        PMID: 25387048     DOI: 10.1097/IAE.0000000000000388

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  6 in total

1.  'Shadow sign' in congenital hypertrophy of the retinal pigment epithelium of young myopic pigmented patients.

Authors:  M Y Chang; J B McBeath; C A McCannel; T A McCannel
Journal:  Eye (Lond)       Date:  2015-10-16       Impact factor: 3.775

2.  Ultra-Widefield Steering-Based Spectral-Domain Optical Coherence Tomography Imaging of the Retinal Periphery.

Authors:  Netan Choudhry; John Golding; Matthew W Manry; Rajesh C Rao
Journal:  Ophthalmology       Date:  2016-03-16       Impact factor: 12.079

3.  Multimodal imaging of the retina and choroid in healthy Macaca fascicularis at different ages.

Authors:  Shuxin Fan; Xiaoyan Ding; Pinhong Rao; Yingfeng Zheng; Fuxiang Mao; Youjin Hu; Xialin Liu; Guoping Fan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-25       Impact factor: 3.117

4.  Evolving Longitudinal Retinal Observations in a Cohort of Survivors of Ebola Virus Disease.

Authors:  Paul J Steptoe; Fayiah Momorie; Alimamy D Fornah; Patrick Komba; Elizabeth Emsley; Janet T Scott; Samantha J Williams; Simon P Harding; Matthew J Vandy; Foday Sahr; Nicholas A V Beare; Malcolm G Semple
Journal:  JAMA Ophthalmol       Date:  2020-04-01       Impact factor: 7.389

5.  Analysis of White and Dark without Pressure in a Young Myopic Group Based on Ultra-Wide Swept-Source Optical Coherence Tomography Angiography.

Authors:  Huimin Yu; Huan Luo; Xian Zhang; Jinfu Sun; Zheng Zhong; Xufang Sun
Journal:  J Clin Med       Date:  2022-08-18       Impact factor: 4.964

6.  Diffuse Outer Layer Opacification: A Novel Finding in Patients With Autosomal Recessive Bestrophinopathy.

Authors:  Emily Witsberger; Alan Marmorstein; Jose Pulido
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019 Nov-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.